DK132172B - Analogifremgangsmåde til fremstilling af 6,7-benzomorphaner eller salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 6,7-benzomorphaner eller salte deraf.

Info

Publication number
DK132172B
DK132172B DK288270AA DK288270A DK132172B DK 132172 B DK132172 B DK 132172B DK 288270A A DK288270A A DK 288270AA DK 288270 A DK288270 A DK 288270A DK 132172 B DK132172 B DK 132172B
Authority
DK
Denmark
Prior art keywords
benzomorphans
salts
preparation
analogous process
analogous
Prior art date
Application number
DK288270AA
Other languages
English (en)
Other versions
DK132172C (da
Inventor
A M Akkerman
P A J Janssen
Original Assignee
Acf Chemiefarma Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL6908528A external-priority patent/NL158787B/xx
Priority claimed from NL6908527A external-priority patent/NL6908527A/xx
Priority claimed from NL6908529A external-priority patent/NL156047B/xx
Application filed by Acf Chemiefarma Nv filed Critical Acf Chemiefarma Nv
Priority to DK135472A priority Critical patent/DK130831B/da
Priority to DK135672A priority patent/DK142619B/da
Priority to DK135572A priority patent/DK135586B/da
Publication of DK132172B publication Critical patent/DK132172B/da
Application granted granted Critical
Publication of DK132172C publication Critical patent/DK132172C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cartons (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK288270A 1969-06-04 1970-06-03 Analogifremgangsmade til fremstilling af 6,7-benzomorphaner eller salte deraf DK132172C (da)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DK135472A DK130831B (da) 1969-06-04 1972-03-22 Substituerede 2-benzyl-4-piperidoner til anvendelse som mellemprodukter ved fremstilling af benzomorphaner, og fremgangsmåde til deres fremstilling.
DK135672A DK142619B (da) 1969-06-04 1972-03-22 Substituerede 2-benzyl-4-piperidoner til anvendelse som mellemprodukter ved fremstilling af benzomorphaner, og fremgangsmåde til deres fremstilling.
DK135572A DK135586B (da) 1969-06-04 1972-03-22 Substituerede 2-benzyl-4-piperidinoler til anvendelse som mellemprodukter ved fremstilling af benzomorphaner.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL6908528A NL158787B (nl) 1969-06-04 1969-06-04 Werkwijze ter bereiding van gesubstitueerde 2-benzyl-4-piperidonen en 2-benzyl-4-piperidinolen en zouten van deze verbindingen.
NL6908527A NL6908527A (en) 1969-06-04 1969-06-04 Benzomorphanes as analgesics and morphine- - autogenists
NL6908529A NL156047B (nl) 1969-06-04 1969-06-04 Werkwijze voor de bereiding van farmaceutische preparaten met analgetische en/of morfine-antagonistische werking, gevormde preparaten, alsmede werkwijze voor de bereiding van daartoe geschikte nieuwe 6,7-benzomorfanen.

Publications (2)

Publication Number Publication Date
DK132172B true DK132172B (da) 1975-11-03
DK132172C DK132172C (da) 1976-03-29

Family

ID=27351494

Family Applications (1)

Application Number Title Priority Date Filing Date
DK288270A DK132172C (da) 1969-06-04 1970-06-03 Analogifremgangsmade til fremstilling af 6,7-benzomorphaner eller salte deraf

Country Status (17)

Country Link
US (1) US3764606A (da)
JP (1) JPS496907B1 (da)
CA (1) CA935430A (da)
CH (2) CH566989A5 (da)
DE (1) DE2027077A1 (da)
DK (1) DK132172C (da)
ES (3) ES380352A1 (da)
FI (1) FI53310C (da)
FR (1) FR2052930B1 (da)
GB (1) GB1299669A (da)
IE (1) IE34235B1 (da)
IT (1) IT1043829B (da)
LU (1) LU61000A1 (da)
NO (2) NO133496C (da)
PH (1) PH10082A (da)
PL (1) PL82622B1 (da)
SE (2) SE374368B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155999B (da) * 1974-04-18 1989-06-12 Bristol Myers Co Analogifremgangsmaade til fremstilling af benzomorphanderivater

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010164A (en) * 1973-03-28 1977-03-01 Boehringer Ingelheim Gmbh N-(furyl-methyl)-2-hydroxy-5,9,9-trimethyl-benzomorphans and salts thereof
US3853889A (en) * 1973-07-18 1974-12-10 Bristol Myers Co 3,14-substituted-8-oxamorphinans
US3959290A (en) * 1973-07-18 1976-05-25 Bristol-Myers Company 3,14-Substituted-8-oxamorphinans
US3892757A (en) * 1973-08-29 1975-07-01 Purdue Research Foundation Trialkylmethanobenzazocinols
US3891658A (en) * 1973-08-29 1975-06-24 Purdue Research Foundation N-Phenethyl trialkylmethanobenz-azolines
GB1513961A (en) * 1975-02-25 1978-06-14 Acf Chemiefarma Nv 6,7-benzomorphans method for their preparation and intermediates
US4127577A (en) * 1975-11-24 1978-11-28 Sterling Drug Inc. Aminomethanobenzazocine process
US4205171A (en) * 1976-01-12 1980-05-27 Sterling Drug Inc. Aminomethanobenzazocines and nitromethanobenzazocines
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
US4208523A (en) * 1978-11-30 1980-06-17 Sterling Drug Inc. 11-Lower-alkyl-, 11-phenyl-lower-alkyl- and 11-cyclo-lower-alkyl-lower-alkyl-hexahydro-2,6-methano-3-benzazocines
US5010083A (en) * 1988-03-28 1991-04-23 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-methano-1,3-benzodiazocine compounds which have useful pharmaceutical utility
US5097033A (en) * 1988-03-28 1992-03-17 Hoechst-Roussel Pharmaceuticals Inc. 2,6-methano-1,3-benzodiazocine compounds
US5264575A (en) * 1988-03-28 1993-11-23 Hoechst-Roussel Pharmaceuticals Inc. Process of preparing 2,6-methano-1,3-benzodiazocine compounds
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan
US6136980A (en) * 1998-05-01 2000-10-24 Boehringer Ingelheim Kg Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane
DE19822822A1 (de) * 1998-05-20 1999-11-25 Boehringer Ingelheim Pharma Verbessertes Verfahren zur Herstellung von pharmazeutisch wertvollen Norbenzomorphanderivaten
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP1506174B1 (en) 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP6182620B2 (ja) * 2013-01-31 2017-08-16 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997637A (en) * 1962-01-31 1965-07-07 Smith Kline French Lab Substituted 2-cyclopropylmethyl-6,7-benzmorphans
US3250678A (en) * 1963-01-16 1966-05-10 Sterling Drug Inc Analgesia producing benzazocines
NL130089C (da) * 1963-11-07
US3345373A (en) * 1964-05-25 1967-10-03 Smith Kline French Lab 2-polymethylallyl-5, 9-dimethyl-6, 7-benzmorphans and derivatives
US3322778A (en) * 1964-05-26 1967-05-30 Smith Kline French Lab Novel ether derivatives of benzmorphans
DE1545792B2 (de) * 1965-02-27 1975-08-07 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 4-Hydroxyplperidinen
DE1545827C3 (de) * 1965-06-25 1975-09-11 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 6,7-Benzomorphanen
NL132138C (da) * 1966-05-20
NL132139C (da) * 1966-05-20
US3553223A (en) * 1968-01-05 1971-01-05 Hoffmann La Roche Acid catalyzed cyclization of tetrahydropyridines containing an electron withdrawing group on the nitrogen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155999B (da) * 1974-04-18 1989-06-12 Bristol Myers Co Analogifremgangsmaade til fremstilling af benzomorphanderivater

Also Published As

Publication number Publication date
US3764606A (en) 1973-10-09
DK132172C (da) 1976-03-29
GB1299669A (en) 1972-12-13
LU61000A1 (da) 1970-07-28
FR2052930B1 (da) 1974-10-11
CH546241A (de) 1974-02-28
CH566989A5 (da) 1975-09-30
PH10082A (en) 1976-08-12
NO133496C (da) 1976-05-12
PL82622B1 (da) 1975-10-31
JPS496907B1 (da) 1974-02-16
IE34235L (en) 1970-12-04
FI53310C (fi) 1978-04-10
NO751399L (da) 1970-12-05
SE374368B (da) 1975-03-03
NO133496B (da) 1976-02-02
CA935430A (en) 1973-10-16
IT1043829B (it) 1980-02-29
NO137091B (no) 1977-09-19
FR2052930A1 (da) 1971-04-16
IE34235B1 (en) 1975-03-19
ES380352A1 (es) 1973-04-16
SE400277B (sv) 1978-03-20
DE2027077A1 (de) 1970-12-17
NO137091C (no) 1977-12-28
ES407194A1 (es) 1976-02-01
ES407195A1 (es) 1976-02-01
FI53310B (da) 1977-12-30

Similar Documents

Publication Publication Date Title
DK131725B (da) Analogifremgangsmåde til fremstilling af 2,4-diaminoquinazoliner eller salte deraf.
DK132172B (da) Analogifremgangsmåde til fremstilling af 6,7-benzomorphaner eller salte deraf.
DK134113B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-7-halogen-eller 7-trifluormethyl-6-sulfamyl-4-quinazolinoner eller salte heraf.
DK139869B (da) Analogifremgangsmåde til fremstilling af phenyl-imidazolyl-alkansyrederivater eller salte deraf.
DK124031B (da) Analogifremgangsmåde til fremstilling af fenylsubstituerede piperazinylalkylaminouraciler, -uracilætere eller -uraciltioætere eller salte deraf.
DK126788B (da) Analogifremgangsmåde til fremstilling af γ-morpholino-p-amino-butyrophenoner eller salte deraf.
DK129650B (da) Analogifremgangsmåde til fremstilling af 1-phenoxy-2-hydroxy-3-amino-propaner eller salte deraf.
DK128078B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater eller salte deraf.
DK123708B (da) Fremgangsmåde til fremstilling af polyencarboxylsyrer eller salte deraf.
DK137758B (da) Analogifremgangsmåde til fremstilling af 2-(5-nitro-2-imidazolyl)-benzimidazoler eller salte deraf.
DK123032B (da) Analogifremgangsmåde til fremstilling af 1-phenoxymethyl-3,4-dihydro- og -1,2,3,4-tetrahydro-isoquinolin-forbindelser eller salte deraf.
DK133979B (da) Analogifremgangsmåde til fremstilling af 5-methyl-10-(beta-alkylaminethyl)-dibenzo(b,f)-azepiner eller salte deraf.
DK127424B (da) Analogifremgangsmåde til fremstilling af 4-aryl-1-(4,4-diarylbutyl)-4-hydroxypiperidiner eller syreadditionssalte deraf.
DK131374B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf.
DK123242B (da) Analogifremgangsmåde til fremstilling af 3-(5-nitro-2-imidazolylmetylenamino)-2-oksazolidinoner eller salte deraf.
DK133778B (da) Analogifremgangsmåde til fremstilling af substituerede isoquinoliner eller salte heraf.
DK127432B (da) Analogifremgangsmåde til fremstilling af acylaminopenicillansyrer eller salte deraf.
DK118509B (da) Fremgangsmåde til fremstilling af 1,1-diphenyl-1-metoxy-3-benzylaminopropan eller salte heraf.
DK124885B (da) Analogifremgangsmåde til fremstilling af 4-alkenyl-substituerede 1,2-difenyl-3,5-dioxopyrazolidiner eller salte heraf.
DK124035B (da) Fremgangsmåde til fremstilling af α-carboxybenzylpencillin eller salte deraf.
DK126201B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf.
DK134557B (da) Analogifremgangsmåde til fremstilling af estere af alfa-amino-aryl-eller thienylmetylpenicilliner eller salte heraf.
DK120796B (da) Analogifremgangsmåde til fremstilling af 1,2-oxazinderivater eller salte deraf.
DK140256B (da) Analogifremgangsmåde til fremstilling af 2-alkyl-5-thiazolcarboxylsyrer eller salte deraf.
DK124545B (da) Analogifremgangsmåde til fremstilling af bisimidazolyl-bisphenylmethaner eller salte deraf.